Skip to content
Legislation to reauthorize Food and Drug Administration (FDA) user fee agreements passed the House with bipartisan support Wednesday, and the Senate is expected to […]
House votes to reauthorize FDA user fees; Senate’s up next Read More »
A May 16 letter signed by 125 patient advocacy groups urges congressional leaders to restore the access to COVID treatment for the uninsured that
Patient groups urge lawmakers to restore access to COVID treatment Read More »
Novavax’s two-dose vaccine against COVID-19 moved closer to Emergency Use Authorization (EUA) from the Food and Drug Administration yesterday when the FDA’s Vaccines and
FDA advisory committee recommends EUA for Novavax COVID vaccine Read More »
Projected Medicare Part D costs in 2022 are slightly lower than in 2021 and slower growth in overall drug prices is one of the
Medicare trustees say they expect Part D costs to fall in 2022 Read More »
Since health officials confirmed the first recent case of monkeypox in a human on May 7, the virus has now spread to more than
Yes, we have a monkeypox vaccine – thanks to investment in medical preparedness Read More »
While consumer acceptance of gene-edited food is low, giving shoppers the facts about the benefits of this food can change attitudes and improve uptake,
Report finds information improves consumer attitudes on gene-edited food Read More »
A recently released index ranking shows that the United States, like practically every other country, is falling well short of its climate-change targets. According
U.S. falls short of climate goals, but biotech offers help Read More »
Agriculture Secretary Tom Vilsack in a hearing on Thursday promised the Senate Agriculture Committee that his office is working to ensure Mexico continues to
Vilsack tells Senate GMO corn exports to Mexico will continue Read More »
A bipartisan bill introduced in the Senate would take aim at the opaque pharmacy benefit manager (PBM) system to improve transparency in a scheme
Bill would add transparency to pharmacy benefit manager system Read More »
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), has been included in Washingtonian Magazine’s 2022 list of Washington D.C.’s 500
BIO’s Dr. Michelle McMurry-Heath among DC’s 500 Most Influential People Read More »
